Found 0 matching trials
High Throughput Drug Sensitivity Assay and Genomics- Guided Treatment of Patients With Relapsed or Refractory Acute Leukemia
NAThis pilot clinical trial studies the feasibility of choosing treatment bas...
Location
Fred Hutch/University of Washington Cancer Consortium
Monoclonal Antibody Therapy Plus Etoposide in Treating Patients With Neuroblastoma
PHASE2RATIONALE: Monoclonal antibodies can locate tumor cells and either kill the...
Location
Memorial Sloan-Kettering Cancer Center
AMD3100 Plus Mitoxantrone, Etoposide and Cytarabine in Acute Myeloid Leukemia
PHASE1This study is a phase I/II study to determine the safety and efficacy of AM...
Location
Washington University
Clinical Study of First-line Treatment of Small Cell Lung Cancer (SCLC) With Anlotinib Hydrochloride
PHASE4This study was designed to investigate the efficacy and side effects of com...
Location
Multiple Locations
Reduced Intensity Radio-chemotherapy for Stage IIA/B Seminoma
PHASE2The trial investigates a stage-adapted (stage IIA or IIB) de-escalation of ...
Status
Active Not Recruiting
Location
Rotkreuzklinikum München
Treatment of Burkitt Lymphoma/Leukemia and B Large Cell NHL
PHASE2This is a pilot study to demonstrate that the modified LMB-89 treatment reg...
Location
St. Jude Children's Research Hospital
BRIDGE-NK: Immunotherapy Versus Chemotherapy Induction Followed by Autologous HSCT in Advanced NKTCL
PHASE3This is a randomized, open-label, prospective, multicenter phase III superi...
Location
Fudan University Shanghai Cancer Center,
Phase 1 Study of M9466 Combined With Carboplatin and Platinum-based Anticancer Therapy (DDRiver 521)
PHASE1The purpose of this study is to evaluate the safety, tolerability, pharmaco...
Location
Multiple Locations
N10: A Study of Reduced Chemotherapy and Monoclonal Antibody (mAb)-Based Therapy in Children With Neuroblastoma
PHASE2The purpose of this study is to find out whether N10 chemotherapy is a safe...
Location
Memorial Sloan Kettering Cancer Center
Multidisciplinary Approach for Poor Prognosis Sinonasal Tumors in Inoperable Patients
PHASE2Sinonasal tumors are rare diseases, as they account for the 0.2 % - 0.8 % o...
Location
Presidio Ospedaliero Spedali Civili di Brescia